1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC).
Saved in:
| Title: | 1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC). |
|---|---|
| Authors: | Reck, M.1 (AUTHOR), Mileham, K.F.2 (AUTHOR), Clump, D.A.3 (AUTHOR), Decoster, L.4 (AUTHOR), Estival, A.5 (AUTHOR), Felip, E.6 (AUTHOR), Fried, P.7 (AUTHOR), Paz-Ares, L.8 (AUTHOR), Sebastian, M.9 (AUTHOR), Segarra, N. Vinolas10 (AUTHOR), Surmont, V.11 (AUTHOR), Wagner, A.12 (AUTHOR), Galdy, S.M.13 (AUTHOR), Smit, E.F.14 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS897-S898. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.1734 |
